Meeting
2021 Gastrointestinal Cancers Symposium
Impact of gender on treatment and survival of patients with esophageal cancer in the United States.
Authors
Camille Baumrucker
Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
Camille Baumrucker , Dido Franceschi , Alan S Livingstone , Francis Igor Macedo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Esophageal and Gastric Cancer
Track
Esophageal and Gastric Cancer
Sub Track
Cancer Disparities
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 173)
DOI
10.1200/JCO.2021.39.3_suppl.173
Abstract #
173
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Preoperative chemoradiation versus preoperative chemotherapy alone for esophageal cancer: Higher response rates but equivalent survival.
First Author: Brendon Matthew Stiles
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Unveiling survival strategies: The impact of treatment modalities on patients with esophageal cancer and the role of racial disparities.
First Author: Dani Ran Castillo
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Trimodality therapy with carboplatin/paclitaxel (CP) or FOLFOX (FFX) for esophageal/esogastric junctional cancer (EC/EGJ): Expanded safety and efficacy data from PROTECT.
First Author: Antoine Adenis
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Definitive chemoradiation for oligometastatic esophageal cancer patients.
First Author: Lindsay Puckett